{"id":"https://genegraph.clinicalgenome.org/r/40852a3c-2c7a-413d-8e9a-1f4ecc6b66c1v1.0","type":"EvidenceStrengthAssertion","dc:description":"The relationship between COX10 and Leigh syndrome spectrum was evaluated using the ClinGen Clinical Validity Framework as of April 22, 2019. 14 articles were reviewed.  COX10 was first reported in relation to autosomal recessive Leigh syndrome spectrum in 2003 (Antonicka et al., PMID: 12928484).  Six unique variants predicted to cause a loss of or reduced function of the protein have been reported in ClinVar.  Complex IV deficiency is the mechanism of disease for this gene. Evidence supporting this gene-disease relationship includes case-level data and experimental data. Variants in this gene have been reported in at least 2 probands with Leigh syndrome spectrum in 2 different publications (PMID 12928484, 15455402). This gene-disease association is further supported by the function of the gene product, expression, and studies in patient cell lines and COX10 mouse models.  In summary, there is moderate evidence to support the relationship between COX10 and autosomal recessive Leigh syndrome spectrum. This classification was approved by the NICHD U24 ClinGen Mitochondrial Disease Gene Curation Expert Panel on April 22, 2019 (SOP Version 6).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/40852a3c-2c7a-413d-8e9a-1f4ecc6b66c1","GCISnapshot":"https://genegraph.clinicalgenome.org/r/48794019-db9d-47c2-9977-4dc76a7d07b3","calculatedEvidenceStrength":"Moderate","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/48794019-db9d-47c2-9977-4dc76a7d07b3_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10027","date":"2020-09-01T00:00:00Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/48794019-db9d-47c2-9977-4dc76a7d07b3_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10027","date":"2019-05-20T18:28:01.393Z","role":"Approver"}],"curationReasonDescription":"","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/48794019-db9d-47c2-9977-4dc76a7d07b3_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4d771e1b-8289-4045-9576-abf559a91e4a_proband_score_evidence_line","type":"EvidenceLine","dc:description":"The underlying genetic defect in patient was identified by functional complementation using a panel of retroviral vectors expressing individual human COX assembly genes (16). COX activity in cultured fibroblasts derived from patients S was specifically restored by overexpression of a cDNA coding for COX10. Overexpression of cDNAs of other COX assembly factors, including COX15, which is also involved in mitochondrial heme biosynthesis, failed to complement the COX deficiency. Max scoring for missense mutation was given due to strength of complementation rescue.","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6b1bc1d5-532b-4ded-a604-cd7bad86f5cb","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12928484","rdfs:label":"Antonicka Patient S","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":18,"detectionMethod":"Researchers amplified and sequenced the 1332 bp RTâ€“PCR cDNA, and all seven exons of the COX10 gene in fibroblasts from patient S to search for mutations in the COX10 gene. DNA","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Brain MRI analysis showed severe symmetrical lesions in the putamen and pallidum typical of Leigh syndrome. COX activity in a muscle biopsy was decreased to 16% of the lowest control values, while the other respiratory enzymes activities were normal.","phenotypes":["obo:HP_0001263","obo:HP_0003128"],"previousTesting":false,"previousTestingDescription":"","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/4d771e1b-8289-4045-9576-abf559a91e4a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12928484","allele":[{"id":"https://genegraph.clinicalgenome.org/r/d120497e-3c65-4320-a2c0-551905dafbde","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001303.3(COX10):c.1007A>G (p.Asp336Gly)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/7526"}},{"id":"https://genegraph.clinicalgenome.org/r/59253b3a-1582-4696-9337-ff06ea4c90b5","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001303.3(COX10):c.1007A>T (p.Asp336Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/7525"}}]}}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/b8502ff7-7ab2-4ca3-aca3-145f76ce683f_proband_score_evidence_line","type":"EvidenceLine","dc:description":"The c.2T>C transition results in the abolition of the start site for protein translation.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ada65b9e-0427-4fc5-a297-f496b6f5f362","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15455402","rdfs:label":"Coenen index","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":5,"detectionMethod":"","phenotypeFreeText":"Brain MRI was consistent with Leigh syndrome. MRI of the brain showed slight atrophy and hyperintense lesions in the thalamus, olives, and the nucleus ruber, a pattern comparable to Leigh like disease. Biochemical COX activity was significantly reduced in muscle and fibroblasts (0.15 COX/citrate synthase [CS]; control range, 0.52-2.08; and 0.22 COX/CS; control range, 0.68-1.19 COX/CS, respectively).","phenotypes":["obo:HP_0001263","obo:HP_0003128","obo:HP_0001252"],"previousTesting":false,"previousTestingDescription":"","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/b8502ff7-7ab2-4ca3-aca3-145f76ce683f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15455402","allele":{"id":"https://genegraph.clinicalgenome.org/r/9506ea35-dfc6-41f7-8314-ec2e22ae4db2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001303.3(COX10):c.2T>C (p.Met1Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/7527"}}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":3.5},{"id":"https://genegraph.clinicalgenome.org/r/48794019-db9d-47c2-9977-4dc76a7d07b3_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/48794019-db9d-47c2-9977-4dc76a7d07b3_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a052c5cc-2618-41be-8b16-6933269ddb4a","type":"EvidenceLine","dc:description":"Utilized model scoring system developed for Leigh syndrome experimental evidence. (1/3 pts for neuropathology evidence, 1/1 pts for biochemical abnormalities, 1/1 pts for neurocognitive behavioral differences)","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/53659397-9038-476d-b660-b7f259e8e1f2","type":"Finding","dc:description":"Model system demonstrated biochemical abnormalities consisted with Leigh syndrome (reduced COX activity and levels of Complex IV subunit COX1) along with neurocognitive abnormalities. Neuropathologically, the mice showed shrinkage of the forebrain and reduction in cell density consistent with areas of pathology seen in human patients with Leigh syndrome.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17715058","rdfs:label":"Neuron specific COX10 KO","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":3}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/48794019-db9d-47c2-9977-4dc76a7d07b3_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/11db20e3-30a8-42c8-a43a-420124b90407","type":"EvidenceLine","dc:description":"One patient cell culture model with disrupted gene function showing mitochondrial dysfunction in a non-neuronal cell type (Awarded 1 pt)","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/18176c5a-15af-46c5-9b35-4be635db7ade","type":"FunctionalAlteration","dc:description":"Fibroblasts established from patient with known COX10 mutations (discussed in Valnot et al 2000 PMID:10767350) demonstrated reduced complex IV activity, subunit steady state levels, cytochrome C oxidase holoenzyme, as well as an accumulation of complex IV subassemblies.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14607829","rdfs:label":"COX10 patient cells"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/309124f6-8595-4656-a52c-c47b3733a04d","type":"EvidenceLine","dc:description":"A second patient cell culture model with disrupted gene function showing mitochondrial dysfunction in a non-neuronal cell type (Awarded 0.5 pt)","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ff5ea6ea-d7ca-4b0f-8385-4a06c7667404","type":"FunctionalAlteration","dc:description":"Protein extracted from patient muscle harboring COX10 mutations was studied using blue native polyacrylamide gel electrophoresis. Immunoblots revealed no detectable Complex IV holoenzyme with no abnormal subassemblies. Reduced steady state levels of MTCO1 were also seen in patient muscle and fibroblasts.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24100867","rdfs:label":"Patient muscle study"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/48794019-db9d-47c2-9977-4dc76a7d07b3_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c6ebb04a-d79f-47b6-bfbb-fb22c3b19cf6","type":"EvidenceLine","dc:description":"The encoded protein shares a biochemical relationship or function with 2-5 gene products whose dysfunction is known to cause Leigh syndrome receiving an increased score of 1 pt","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ec9f4a69-475e-4e54-8a16-9dfc82d0a015","type":"Finding","dc:description":"COX10 is a farnesyltransferase that catalyzes the conversion of heme B to heme O in the heme synthesis pathway with the final product heme A being essential for COX function. The importance of COX10 in the assemby of Complex IV is demonstrated by mutations in COX10 showing decreased Complex IV assembly and activity in both yeast and human cells (PMID: 2167310 and PMID: 14607829). Thus, COX10 falls into the category of a complex IV assembly unit.  According to Leigh map at least 4 other complex IV assembly units (PET100, COX15, SURF1, and SCO2) have been implicated in causing Leigh syndrome (Rahman et al 2017 PMID: 27977873). Therefore the function of COX10 is shared with other known genes in the disease of interest.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/2167310","rdfs:label":"Complex IV Assembly Unit","demonstrates":{"id":"cg:BiochemicalFunctionA"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/f91ae8df-6951-4564-9512-55bd8e922d1b","type":"EvidenceLine","dc:description":"Evidence showing that protein expression is disrupted in any tissue or cell type and/or evidence expression in the brain. (Awarded 0.5 pts)","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/12cf1c21-e2cf-47fe-ad43-cf2cff411527","type":"Finding","dc:description":"The Human Protein Atlas Atlas demonstrates that COX10 protein is ubiquitously expressed (https://www.proteinatlas.org/ENSG00000006695-COX10/tissue) Expression in the brain has been shown in the cerebral cortex, caudate, and cerebellum. Points can be awarded as this expression profile is consistent with areas of pathology in Leigh-like syndrome.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25613900","rdfs:label":"Human Atlas brain expression","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":6}],"evidenceStrength":"Moderate","sequence":545,"specifiedBy":"GeneValidityCriteria6","strengthScore":9.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/hSljTnfw_l4","type":"GeneValidityProposition","disease":"obo:MONDO_0009723","gene":"hgnc:2260","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_48794019-db9d-47c2-9977-4dc76a7d07b3-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}